Decimate-C Anticancer Foundation
Fights cancer through research and development, founded in 2021.
2012 | Pune, Maharashtra (India) | Active
Decimate-C Anticancer Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -56.11%
- Profit Growth -405.38%
- Ebitda -6.83%
- Net Worth -79.31%
- Total Assets -75.10%
About Decimate-C Anticancer Foundation
Decimate-C Anticancer Foundation (DAF) is a Private Not For Profit Company incorporated in India on 27 December 2012 and has a history of 12 years and two months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Arundhati Ranade, Prerana Patil, and Rhucha Dasare serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85100PN2012NPL145805
- Company No.
145805
- Company Classification
Private Not For Profit Company
- Incorporation Date
27 Dec 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Healthcare
Decimate-C Anticancer Foundation
Explore comprehensive data for Decimate-C Anticancer Foundation, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Decimate-C Anticancer Foundation?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arundhati Ranade  | Director | 17-Jan-2017 | Current |
| Prerana Patil | Director | 18-Dec-2019 | Current |
| Rhucha Dasare | Director | 18-Dec-2019 | Current |
Financial Performance of Decimate-C Anticancer Foundation.
Decimate-C Anticancer Foundation, for the financial year ended 2022, experienced significant reduction in revenue, with a 56.11% decrease. The company also saw a substantial fall in profitability, with a 405.38% decrease in profit. The company's net worth observed a substantial decline by a decrease of 79.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Decimate-C Anticancer Foundation?
In 2020, Decimate-C Anticancer Foundation had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Decimate-C Anticancer Foundation?
Unlock and access historical data on people associated with Decimate-C Anticancer Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Decimate-C Anticancer Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Decimate-C Anticancer Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Decimate-C Anticancer Foundation
Recent activity within the organization
- Annual General Meeting
Decimate-C Anticancer Foundation last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Decimate-C Anticancer Foundation has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Pune.
- Director Appointment
Prerana Prasad Patil was appointed as a Director was appointed as a Director on 18 Dec 2019 & has been associated with this company since 5 years 3 months .
- Director Appointment
Rhucha Rahul Dasare was appointed as a Director was appointed as a Director on 18 Dec 2019 & has been associated with this company since 5 years 3 months .
- Director Appointment
Arundhati Anil Ranade was appointed as a Director was appointed as a Director on 17 Jan 2017 & has been associated with this company since 8 years 2 months .
- Company Incorporation
Decimate-C Anticancer Foundation was registered on 27 Dec 2012 with Roc Pune & aged 12 years 2 months as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Decimate-C Anticancer Foundation?
Decimate-C Anticancer Foundation was incorporated on 27 Dec 2012.
What is authorized share capital and paid-up capital of Decimate-C Anticancer Foundation?
The authorized share capital of Decimate-C Anticancer Foundation is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Decimate-C Anticancer Foundation?
Currently 3 directors are associated with Decimate-C Anticancer Foundation.
- Arundhati Anil Ranade
- Prerana Prasad Patil
- Rhucha Rahul Dasare
What is the registered address of Decimate-C Anticancer Foundation?
As per Ministry of Corporate Affairs (Mca), the registered address of Decimate-C Anticancer Foundation is Office No. 8 4Th Floor Amit Complex Opp - New English School Tilak Road, Sadashiv Peth India, Pune, Maharashtra, 411030.
What is the corporate identification number (CIN) and company number of Decimate-C Anticancer Foundation?
The corporate identification number (CIN) of Decimate-C Anticancer Foundation is U85100PN2012NPL145805 and the company number is 145805 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Decimate-C Anticancer Foundation?
According to the financial reports for the fiscal year 2022, the revenue trend for Decimate-C Anticancer Foundation has fallen by -56.11%.
What change has been observed in the net worth of Decimate-C Anticancer Foundation, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Decimate-C Anticancer Foundation has experienced an downturn of -79.31%.
When was the last Balance Sheet of Decimate-C Anticancer Foundation filed with the ROC?
The most recent Balance Sheet for Decimate-C Anticancer Foundation was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
AR
Anantbhushan RanadeDirectorGP
Girish PhadkeDirectorAP
Amit ParasnisDirectorAR
Anil RanadeDirector